From 2022 to 2032, the global interventional cardiology devices market is anticipated to expand at a compound annual growth rate of 8.4%. By 2022 and 2032, the interventional cardiology devices market is projected to be valued US$ 16.4 billion and US$ 36.9 billion, respectively.
Factors driving market growth include the increasing elderly population leading to a rise in coronary artery disease prevalence, as well as the introduction of new and advanced products, and a rising incidence of diabetes.
However, the availability of alternative therapies, as well as product failures and recalls, may limit market growth during the forecast period. Additionally, hospital visits have decreased due to lockdowns and social distancing, leading to lower sales for interventional cardiology products.
Leading companies in the Interventional Cardiology Devices market, including Boston Scientific, Medtronic, and Abbott, have reported revenue reductions in recent quarters. Despite this, the demand for interventional cardiology devices is expected to rise due to the high incidence of heart and circulation diseases, particularly in the United Kingdom.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-14684
Risk factors such as diabetes and hypertension also contribute to the demand for interventional cardiology equipment, with a rising prevalence of these conditions expected in major markets as the world’s population ages. Emerging markets such as India, China, and Brazil offer significant potential opportunities for the industry due to a large geriatric population and high diabetes incidence.
Of all interventional cardiology devices, angiography catheters hold the largest market share due to the high prevalence of coronary artery disease and growing awareness of early identification.
North America currently dominates the market due to factors such as growing diabetes prevalence, an aging population, reimbursement availability, and the presence of major corporations.
KEY TAKEAWAYS:
- In the product sector, Angioplasty Stents from the marketing attribution software market is anticipated to flourish at the quickest CAGR of 8% through 2032.
- With a CAGR of 7.9% through 2032, North America is predicted to grow significantly in the region segment of the marketing attribution software market.
- The market size for marketing attribution software market in the United States is expected to reach US$ 12.9 Billion by 2032, growing at a CAGR of 8.2% through 2032.
- China is anticipated to reach a market size of US$ 2.7 Billion in marketing attribution software by 2032, with a CAGR of 7.8% through 2032.
- UK’s marketing attribution software market is anticipated to be worth US$ 1.5 Billion by 2032, with a CAGR of 7.5% through 2032.
- Japan is expected to have a market size for marketing attribution software of US$ 2.1 Billion by 2032, with a CAGR of 6.7% through 2032.
- By 2032, South Korea is expected to reach a market size of US$ 1.3 Billion in marketing attribution software, with a CAGR of 6.2% through 2032.
COMPETITIVE LANDSCAPE:
Medtronic (US), Boston Scientific Corporation (US), Abbott (US), Edward Lifesciences Corporation (US), Cardinal Health (US), iVascular (Spain), Becton, Dickinson, and Company (US), B. Braun Melsungen (Germany), Terumo Corporation (Japan), Biosensors International Group (Singapore), and BIOTRONIK SE & Co. KGaA are prominent Interventional Cardiology Devices market players (Germany).
Insights Designed for You: Customize Your Exclusive Report Today:
https://www.futuremarketinsights.com/customization-available/rep-gb-14684
Key Segments
By Product:
- Angioplasty Balloons
- Old/Normal Balloons
- Drug-eluting Balloons
- Cutting and Scoring Balloons
- Angioplasty Stents
- Drug-eluting Stents
- Bare-mental Stents
- Bioabsorbable Stents
- Structural Heart Devices
- Aortic Valve Therapy Devices
- Other Therapy Devices
- Catheters
- Angiography Catheters
- Guiding Catheters
- IVUS/OCT Catheters
- Plaque Modification Devices
- Atherectomy Devices
- Thrombectomy Devices
- Hemodynamic Flow Alteration Devices
- Embolic Protection Devices
- Chronic Total Occlusion Devices
- Other Devices
- Guidewires
- Vascular Closure Devices
Unlock exclusive insights with our expert analysts :
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-14684
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
